Antiemetics Market by Product Type, by Application and Geographic: Analysis, Size, Growth, Trends, and Forecast, 2024-2028

Market Size

The antiemetics market supplies drugs and medications that alleviate nausea and vomiting, serving patients with a variety of medical conditions and treatments. Antiemetic drugs are primarily used to manage nausea and vomiting associated with chemotherapy, post-operative surgery, motion sickness, and other conditions such as gastroenteritis and pregnancy-related nausea (morning sickness). They also assist in controlling vertigo, balance problems (vestibular neuritis), and dizziness.

Market Report Highlights

Drug Type	Anticholinergics Antihistamines Receptor Antagonists Others
Application	Chemotherapy Postoperative care Gastroenteritis Others
Regional Landscape	North America Europe APAC South America The Middle East and Africa
Key Companies Profiled	Pfizer Inc. Johnson & Johnson Merck KGaA Cipla Inc. GSK plc

Market Report Insights

Technavio’s in-depth industry report offers historical data as well as a comprehensive market forecast. It analyzes the current state of the antiemetics market and provides detailed predictions on its performance over the coming years. It examines key factors such as market drivers, challenges, and key emerging trends, as well as the global competitive landscape. Also included is a breakdown of the types of products available on the market, along with their market shares and future prospects.

Market Segmentation

The antiemetics market is segmented according to drug type, application, and region. Technavio’s industry report provides actionable market insights on each segment, including market share and growth forecasts. Chemotherapy is a leading application in the antiemetics market due to the rising number of cancer cases globally. Postoperative care applications are also seeing significant growth as advancements in surgical procedures increase the number of surgeries being performed.

Drug Type Segmentation

• Anticholinergics
• Antihistamines
• Receptor Antagonists
• Others

Application Segmentation

• Chemotherapy
• Postoperative care
• Gastroenteritis
• Others

Regional Analysis

Different parts of the world will have different demands, supply chain logistics, legal nuances, and other factors to take into consideration when entering a new market. Technavio’s antiemetics market research helps facilitate strategic business decisions by providing a historical and focused look at regional markets, including market trends, drivers, and challenges as well as predictions for regional market sizes and growth.

Geographical Segmentation:

• North America
  • Segmentation by drug type
  • Segmentation by application
• Europe
  • Segmentation by drug type
  • Segmentation by application
• APAC
  • Segmentation by drug type
  • Segmentation by application
• South America
  • Segmentation by drug type
  • Segmentation by application
• The Middle East and Africa
  • Segmentation by drug type
  • Segmentation by application

Competitive Landscape

This report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies in order to help clients improve their market positions. It also provides a detailed analysis of the upcoming antiemetics market trends and challenges and how they will influence market growth, designed to help companies create effective strategies to make the most of the global market.

Companies leading the global antiemetics market include:

• Pfizer Inc.
• Johnson & Johnson
• Merck KGaA
• Cipla Inc.
• GSK plc

Market Dynamics

In order to make informed business decisions and strategies, it’s important to be informed of the many factors impacting the market. What is driving growth in the market and how does that influence new product releases? What challenges are increasing risk for a specific course of action or in a specific market? What will the key trends be over the next several years and what is the best way to take advantage of them? The answers to these questions help companies to evaluate business approaches and develop growth strategies.

Antiemetic drugs are typically used to treat nausea and vomiting caused by motion sickness or by side effects from other drugs, such as those used in chemotherapies. They can also be used to treat issues such as morning sickness during pregnancy, vertigo, and food poisoning. There is a significant amount of R&D being conducted in the antiemetics market, which is helping to drive growth as new products are developed and put onto the market.  

FAQ

What are the key factors driving the growth of the Antiemetics Market?

Growth drivers include an increasing prevalence of chemotherapy treatments, rising incidence of nausea and vomiting due to various medical conditions, advancements in drug formulations and delivery methods, and expanding healthcare access globally.

How does regulatory oversight impact the Antiemetics Market?

Regulatory agencies such as the FDA (Food and Drug Administration) in the United States and EMA (European Medicines Agency) in Europe set standards for the safety, efficacy, and labeling of antiemetic medications to ensure patient safety and treatment efficacy.

What are the challenges faced by manufacturers in the Antiemetics Market?

Challenges include managing the high cost of drug development and clinical trials, navigating complex regulatory pathways for global market approvals, addressing drug resistance and adverse effects, and meeting diverse patient needs.

What are the future prospects for the Antiemetics Market?

The market is expected to grow with advancements in personalized medicine, increasing research into novel drug targets and formulations, expansion of healthcare infrastructure in emerging markets, and the integration of digital health technologies in patient care.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Exhibit 01: Executive Summary – Chart on Market Overview
  • Exhibit 02: Executive Summary – Data Table on Market Overview
  • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
  • Exhibit 04: Executive Summary – Chart on Market by Geography
  • Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary – Chart on Incremental Growth
  • Exhibit 08: Executive Summary – Data Table on Incremental Growth
  • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 13: Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on North America: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Regional - Market size and forecast 2023-2028 ($ billion)

4 Historic Market Size

• 4.1 Dietary supplements market in North America 2018 - 2022
  • Exhibit 18: Historic Market Size – Data Table on dietary supplements market in north America 2018 - 2022 ($ billion)

• 4.2 Distribution Channel Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)

• 4.3 Product Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

• 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Exhibit 22: Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Exhibit 23: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Exhibit 24: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Exhibit 25: Threat of new entrants – Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Exhibit 26: Threat of substitutes – Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Exhibit 27: Threat of rivalry – Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Exhibit 28: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
  • Exhibit 29: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibit 30: Data Table on Distribution Channel - Market share 2023-2028 (%)

• 6.2 Comparison by Distribution Channel
  • Exhibit 31: Chart on Comparison by Distribution Channel
  • Exhibit 32: Data Table on Comparison by Distribution Channel

• 6.3 Offline - Market size and forecast 2023-2028
  • Exhibit 33: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 34: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Chart on Offline - Year-over-year growth 2023-2028 (%)
  • Exhibit 36: Data Table on Offline - Year-over-year growth 2023-2028 (%)

• 6.4 Online - Market size and forecast 2023-2028
  • Exhibit 37: Chart on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 38: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibit 40: Data Table on Online - Year-over-year growth 2023-2028 (%)

• 6.5 Market opportunity by Distribution Channel
  • Exhibit 41: Market opportunity by Distribution Channel ($ billion)
  • Exhibit 42: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product

• 7.1 Market segments
  • Exhibit 43: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 44: Data Table on Product - Market share 2023-2028 (%)

• 7.2 Comparison by Product
  • Exhibit 45: Chart on Comparison by Product
  • Exhibit 46: Data Table on Comparison by Product

• 7.7 Others - Market size and forecast 2023-2028
  • Exhibit 63: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 64: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 65: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 66: Data Table on Others - Year-over-year growth 2023-2028 (%)

• 7.8 Market opportunity by Product
  • Exhibit 67: Market opportunity by Product ($ billion)
  • Exhibit 68: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Exhibit 69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Exhibit 70: Chart on Market share by geography - 2023-2028 (%)
  • Exhibit 71: Data Table on Market share by geography - 2023-2028 (%)

• 9.2 Geographic comparison
  • Exhibit 72: Chart on Geographic comparison
  • Exhibit 73: Data Table on Geographic comparison

• 9.6 Market opportunity by geography
  • Exhibit 74: Market opportunity by geography ($ billion)
  • Exhibit 75: Data Table on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Exhibit 76: Impact of drivers and challenges in 2023 and 2028

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
  • Exhibit 77: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
  • Exhibit 78: Overview on factors of disruption

• 11.4 Industry risks
  • Exhibit 79: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
  • Exhibit 80: Vendors covered

• 12.2 Market positioning of vendors
  • Exhibit 81: Matrix on vendor position and classification

• 13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Exhibit 82: Inclusions checklist
  • Exhibit 83: Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Exhibit 84: Currency conversion rates for US$

• 13.4 Research methodology
  • Exhibit 85: Research methodology
  • Exhibit 86: Validation techniques employed for market sizing
  • Exhibit 87: Information sources

• 13.5 List of abbreviations
  • Exhibit 88: List of abbreviations